Recombinant Full Length Archaerhodopsin-3(Aop3) Protein, His-Tagged
Cat.No. : | RFL3773HF |
Product Overview : | Recombinant Full Length Archaerhodopsin-3(aop3) Protein (P96787) (7-258aa), fused to N-terminal His tag, was expressed in E. coli. |
- Specification
- Gene Information
- Related Products
- Download
Source : | E.coli expression system |
Species : | Halorubrum sodomense |
Tag : | His |
Form : | Lyophilized powder |
Protein length : | Full Length of Mature Protein (7-258) |
AA Sequence : | QAGYDLLGDGRPETLWLGIGTLLML IGTFYFLVRGWGVTDKDAREYYAVT ILVPGIASAA YLSMFFGIGLTEVTVGGEMLDIYYA RYADWLFTTPLLLLDLALLAKVDRV TIGTLVGVDA LMIVTGLIGALSHTAIARYSWWLFS TICMIVVLYFLATSLRSAAKERGPE VASTFNTLTA LVLVLWTAYPILWIIGTEGAGVVGL GIETLLFMVLDVTAKVGFGFILLRS RAILGDTEAP EPSAGADVSAAD |
Purity : | Greater than 90% as determined by SDS-PAGE. |
Applications : | SDS-PAGE |
Notes : | Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week. |
Storage : | Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles. |
Storage Buffer : | Tris/PBS-based buffer, 6% Trehalose, pH 8.0 |
Reconstitution : | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference. |
Gene Name : | aop3 |
Synonyms : | aop3; Archaerhodopsin-3; AR 3 |
UniProt ID : | P96787 |
Gene Name : | aop3 |
Synonyms : | aop3; Archaerhodopsin-3; AR 3 |
UniProt ID : | P96787 |
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (18)
Ask a questionAOP3 has the ability to target and regulate immune function, which can enhance the immunity of patients, attack cancer cells, and thus improve the therapeutic effect.
AOP3 is currently showing potential in the treatment of many cancer types, including lung, breast, colorectal, and others.
The research focuses on the mechanism of action of AOP3 , effect evaluation, clinical trial design and so on.
No significant side effects of AOP3 have been found, but individual differences still exist, so caution should be monitored during use.
AOP3 has potential applications in tumor therapy, immune regulation, inflammation therapy and other fields.
The safety and efficacy of AOP3 in children and the elderly are still being studied, and more clinical trials are needed to ensure its rational use.
Yes, AOP3 can promote the activation and proliferation of immune cells, and improve the killing ability of immune cells.
AOP3 can play its role by regulating immune response and activating cell signaling pathway.
Yes, AOP3 has shown some efficacy in the treatment of some metastatic cancers.
AOP3 can be used in combination with immunomodulatory drugs, targeted therapy drugs, etc., to improve the therapeutic effect and reduce adverse reactions.
The treatment cycle and duration of AOP3 vary depending on the condition and need to be individualized according to the doctor's recommendation.
At present, the drug dosage form of AOP3 is mainly injection, which is convenient for patients to use.
Yes, AOP3 can be used to treat a variety of immune-related diseases, such as autoimmune diseases, infectious diseases, etc.
Clinical trials of AOP3 are currently in various stages, and some have achieved positive results, but further large-scale trials are still needed to verify its efficacy.
Yes, AOP3 can regulate the immune response, so it can be used to treat some immune diseases, such as rheumatoid arthritis, Crohn's disease, etc.
The production process of AOP3 is mainly based on bioengineering technology, which has the advantages of efficient, controllable and large-scale production.
At present, AOP3 is mainly used for treatment rather than prevention, and research is still continuing to prevent tumor recurrence.
In addition to clinical applications, the study of AOP3 can also be extended to explore its interaction with immune cells, dose optimization and other aspects.
Customer Reviews (4)
Write a reviewStability is very good, and its original performance can be maintained even after multiple uses.
The band strength of AOP3 in Western blot was high, which improved the signal-to-noise ratio of the experiment.
Catalytic activity is very high, which can greatly reduce the time and energy required for chemical reactions, and has high economic value.
Solubility is very good and can be easily dissolved in various buffers.
Ask a Question for All aop3 Products
Required fields are marked with *
My Review for All aop3 Products
Required fields are marked with *
Inquiry Basket